Pigeon fanciers' lung: identification of disease-associated carbohydrate epitopes on pigeon intestinal mucin

C I Baldwin1, A Todd, S J Bourke

  • 1Department of Physiological Sciences, The Medical School, University of Newcastle upon Tyne, UK. c.i.baldwin@newcastle.ac.uk

Insights

Antibodies targeting pigeon intestinal mucin are key in pigeon fanciers' lung (PFL). Different IgG subclasses recognize distinct epitopes, with carbohydrate structures playing a significant role in PFL development.

Area of Science:

  • Immunology
  • Glycobiology
  • Pulmonary Medicine

Background:

  • Pigeon intestinal mucin is a critical antigen in pigeon fanciers' lung (PFL).
  • Understanding antibody specificity to mucin is crucial for PFL pathogenesis research.

Purpose of the Study:

  • To investigate the specificity of anti-mucin antibodies in PFL patients versus asymptomatic individuals.
  • To determine the role of different IgG subclasses and carbohydrate epitopes in PFL.

Main Methods:

  • Papain digestion of mucin to isolate glycosylated regions.
  • Lectin mapping to identify carbohydrate structures on mucin.
  • Inhibition assays using patient sera and lectins.

Main Results:

  • IgG1 and IgG2 antibodies target O-linked sugar chains, while IgG3 targets proteinase-sensitive epitopes.
  • Pigeon intestinal mucin is rich in N-acetyl neuraminic acid, N-acetyl galactosamine, and N-acetyl glucosamine.
  • PFL patients exhibit higher antibody titres against N-acetyl galactosamine and fucose epitopes compared to asymptomatic individuals.

Conclusions:

  • Different IgG subclasses recognize distinct epitopes on pigeon mucin.
  • Carbohydrate structures, particularly N-acetyl galactosamine and fucose, are implicated in PFL pathogenesis.
  • Anti-mucin antibody specificities may differ between PFL patients and asymptomatic carriers.